Epstein–Barr virus‐associated T/natural killer‐cell lymphoproliferative disorders
Authors:
- 18 January 2014
- journal article
- review article
- Published by Wiley in The Journal of Dermatology
- Vol. 41 (1) , 29-39
Abstract
Primary infection with Epstein–Barr virus (EBV) is usually asymptomatic and, in a normal host, EBV remains latent in B cells after primary infection for the remainder of life. Uncommonly, EBV can infect T or natural killer (NK) cells in a person with a defect in innate immunity, and EBV infection can cause unique systemic lymphoproliferative diseases (LPD) of childhood. Primary infection in young children can be complicated by hemophagocytic lymphohistiocytosis or fulminant systemic T‐cell LPD of childhood. Uncommonly, patients can develop chronic active EBV (CAEBV) disease‐type T/NK LPD, which includes CAEBV infection of the systemic form, hydroa vacciniforme‐like T‐cell LPD, and mosquito‐bite hypersensitivity. The clinical course of CAEBV disease‐type T/NK LPD can be smoldering, persistent or progressive, depending on the balance between viral factors and host immunity. Aggressive NK‐cell leukemia, hydroa vacciniforme‐like T‐cell lymphoma, or uncommonly extranodal NK/T‐cell lymphoma can develop in children and young adults with CAEBV disease‐type T/NK‐cell LPD. Extranodal T/NK‐cell lymphoma is a disease of adults, and its incidence begins to increase in the third decade and comprises the major subtype of T/NK LPD throughout life. Aggressive NK‐cell leukemia and nodal T/NK‐cell lymphoma of the elderly are fulminant diseases, and immune senescence may be an important pathogenetic factor. This review describes the current progress in identifying different types of EBV‐associated T/NK‐cell LPD and includes a brief presentation of data from Korea.Keywords
This publication has 108 references indexed in Scilit:
- A Case of Hypersensitivity to Mosquito Bites without Peripheral Natural Killer Cell Lymphocytosis in a 6-Year-Old Korean BoyJournal of Korean Medical Science, 2013
- Subtype distribution of lymphomas in Southwest China: Analysis of 6,382 cases using WHO classification in a single institutionDiagnostic Pathology, 2011
- Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal typeBlood, 2010
- A Case of Hypersensitivity to Mosquito Bite Associated with Epstein-Barr Viral Infection and Natural Killer Cell LymphocytosisJournal of Korean Medical Science, 2010
- Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008Annals of Oncology, 2009
- Systemic EBV+ T-cell lymphoma in elderly patients: comparison with children and young adult patientsVirchows Archiv, 2008
- The Spectrum of Epstein-Barr Virus-Associated Lymphoproliferative Disease in Korea: Incidence of Disease Entities by Age GroupsJournal of Korean Medical Science, 2008
- Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosisJournal of Clinical Pathology, 2007
- Hydroa vacciniforme-like primary cutaneous CD8-positive T-cell lymphomaBritish Journal of Dermatology, 2002
- Atypical hydroa vacciniforme in childhood: From a smoldering stageto Epstein-Barr virus–associated lymphoid malignancyJournal of the American Academy of Dermatology, 1999